Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

Author's Avatar
Jun 07, 2023

ENDRA+Life+Sciences+Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a poster titled “Thermoacoustic assessment of fatty liver disease - an early clinical feasibility study” for presentation at the International Liver Congress 2023 hosted by the European Association for the Study of the Liver (EASL), taking place June 21-24 in Vienna, Austria.